261 related articles for article (PubMed ID: 26587674)
21. Functional Profile of Systemic and Intrathecal Cebranopadol in Nonhuman Primates.
Ding H; Trapella C; Kiguchi N; Hsu FC; Caló G; Ko MC
Anesthesiology; 2021 Sep; 135(3):482-493. PubMed ID: 34237134
[TBL] [Abstract][Full Text] [Related]
22. Discovery of highly selective κ-opioid receptor agonists: 10α-Hydroxy TRK-820 derivatives.
Suzuki S; Sugawara Y; Tsuji R; Tanimura R; Kaneko C; Yuzawa N; Yagi M; Kawai K
Bioorg Med Chem Lett; 2017 Aug; 27(16):3920-3924. PubMed ID: 28688957
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the antinociceptive effects of TRK-820 in the rat.
Endoh T; Tajima A; Suzuki T; Kamei J; Narita M; Tseng L; Nagase H
Eur J Pharmacol; 2000 Jan; 387(2):133-40. PubMed ID: 10650153
[TBL] [Abstract][Full Text] [Related]
24. Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE; Sun HS; Darpolar M; Leitermann RJ; Kampine JP; Tseng LF
J Pharmacol Exp Ther; 2003 Dec; 307(3):1135-41. PubMed ID: 14557378
[TBL] [Abstract][Full Text] [Related]
25. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
Schattauer SS; Kuhar JR; Song A; Chavkin C
Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
[TBL] [Abstract][Full Text] [Related]
26. The role of central mu opioid receptors in opioid-induced itch in primates.
Ko MC; Song MS; Edwards T; Lee H; Naughton NN
J Pharmacol Exp Ther; 2004 Jul; 310(1):169-76. PubMed ID: 15044556
[TBL] [Abstract][Full Text] [Related]
27. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
28. Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
Zamarripa CA; Naylor JE; Huskinson SL; Townsend EA; Prisinzano TE; Freeman KB
Psychopharmacology (Berl); 2020 May; 237(5):1471-1480. PubMed ID: 32006048
[TBL] [Abstract][Full Text] [Related]
29. Modulation of cocaine-related behaviors by low doses of the potent KOR agonist nalfurafine in male C57BL6 mice.
Dunn A; Windisch K; Ben-Ezra A; Pikus P; Morochnik M; Erazo J; Reed B; Kreek MJ
Psychopharmacology (Berl); 2020 Aug; 237(8):2405-2418. PubMed ID: 32435819
[TBL] [Abstract][Full Text] [Related]
30. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
31. Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain/itch-stimulated and pain/itch-depressed behaviors in male rats.
Lazenka ML; Moerke MJ; Townsend EA; Freeman KB; Carroll FI; Negus SS
Psychopharmacology (Berl); 2018 Jan; 235(1):203-213. PubMed ID: 29063139
[TBL] [Abstract][Full Text] [Related]
32. Nonopioidergic mechanism mediating morphine-induced antianalgesia in the mouse spinal cord.
Wu HE; Thompson J; Sun HS; Leitermann RJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 2004 Jul; 310(1):240-6. PubMed ID: 14999057
[TBL] [Abstract][Full Text] [Related]
33. Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice.
Inoue M; Ueda H
J Pharmacol Exp Ther; 2000 May; 293(2):662-9. PubMed ID: 10773042
[TBL] [Abstract][Full Text] [Related]
34. Antinociceptive effects of two deltorphins analogs in the tail-immersion test in rats.
Kotlinska JH; Gibula-Bruzda E; Witkowska E; Chung NN; Schiller PW; Izdebski J
Peptides; 2013 Jan; 39():103-10. PubMed ID: 23183627
[TBL] [Abstract][Full Text] [Related]
35. The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
Tsuji M; Takeda H; Matsumiya T; Nagase H; Narita M; Suzuki T
Life Sci; 2001 Mar; 68(15):1717-25. PubMed ID: 11270618
[TBL] [Abstract][Full Text] [Related]
36. Species Variation in Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception.
Ruan X; Bumgarner GW; Kaye AD
Reg Anesth Pain Med; 2016; 41(3):414. PubMed ID: 27093280
[No Abstract] [Full Text] [Related]
37. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
[TBL] [Abstract][Full Text] [Related]
38. kappa-Opioid agonists produce antinociception after i.v. and i.c.v. but not intrathecal administration in the rat.
Leighton GE; Rodriguez RE; Hill RG; Hughes J
Br J Pharmacol; 1988 Mar; 93(3):553-60. PubMed ID: 2836010
[TBL] [Abstract][Full Text] [Related]
39. Physiological function of gastrin-releasing peptide and neuromedin B receptors in regulating itch scratching behavior in the spinal cord of mice.
Sukhtankar DD; Ko MC
PLoS One; 2013; 8(6):e67422. PubMed ID: 23826298
[TBL] [Abstract][Full Text] [Related]
40. Cross-talk between Human Spinal Cord μ-opioid Receptor 1Y Isoform and Gastrin-releasing Peptide Receptor Mediates Opioid-induced Scratching Behavior.
Liu XY; Ginosar Y; Yazdi J; Hincker A; Chen ZF
Anesthesiology; 2019 Aug; 131(2):381-391. PubMed ID: 31314749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]